Status:
ENROLLING_BY_INVITATION
Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Wide Spectrum of Diseases
Hematologic Diseases
Eligibility:
All Genders
2-120 years
Brief Summary
Background: Researchers seek ways to study people s medical problems in order to teach and further general knowledge. The ability to assess and treat people with a wide range of diseases is critical ...
Detailed Description
This protocol is designed to provide a repository of information to allow for hypothesis generation in future research. This information will be drawn from standard medical care/procedures and follow ...
Eligibility Criteria
Inclusion
- ELIGIBILITY:
- Patients (including those referred to us to rule out a disease or condition) and stem cell donors, may be entered on this protocol at the discretion of the Principal and/or Associate Investigators.
- The patient or the patient's Legally Authorized Representative is capable of informed consent and signs the consent form. The consent form will be signed by parents or guardians of patients under the age of 18.
- Age more than or equal to 2 and weight \> 12 kg
Exclusion
Key Trial Info
Start Date :
June 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2040
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04450927
Start Date
June 16 2020
End Date
December 31 2040
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892